Granulocyte, macrophage, monocyte apheresis for refractory ulcerative proctitis

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 9, 2004, Pages 943-945

  Premchand, Purushothaman ^a,b   Takeuchi, Ken ^a   Bjarnason, Ingvar ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Colectomy; Granulocyte monocyte macrophage adsorption apheresis; Refractory colitis

Indexed keywords

AZATHIOPRINE; CALPROTECTIN;

ADULT; APHERESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; GRANULOCYTE; HUMAN; LABORATORY TEST; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; DRUG RESISTANCE; FEMALE; HUMANS; LEUKAPHERESIS; PROCTITIS;

EID: 4444299017     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200409000-00023     Document Type: Article

References (9)

1. Jewell D. Ulcerative colitis. In: Feldman M, Friedman LS, Sleisenger MH (editors): Gastrointestinal and Liver Diseases (7th edition). Philadelphia, PA: Sanders; 2002, pp. 2039-2067.
2. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ 1955; ii:1041-1048.
3. Falasco G, Zinicola R, Forbes A. Immunosuppressants in distal ulcerative colitis. Aliment Pharmacol Ther 2002; 16:181-187.
4. Rutgeets PJ. Infliximab for ulcerative colitis: the need for adequately powered placebo-controlled trials. Am J Gastroenterol 2002; 97:2488-2489.
5. Hanai H, Watanabe F, Saniabadi AR, Matsushitai I, Takeuchi K, Iida T. Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Clin Gastroenterol Hepatol 2003; 1:28-34.
6. Forbes A, Britton TC, House IM, Gazzard BG. Safety and efficacy of acetarsol in unresponsive proctitis. Aliment Pharmacol Ther 1989; 3:553-556.
7. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002; 123:450-460.
8. Sawada K, Ohnishi K, Fukunaga KJ, Chicano S, Egashira M. Mechanism of leukocytapheresis effect in the treatment of ulcerative colitis. Clin Apheresis 2001; 16:1-9.
9. Rembacken BJ, Newbould HE, Richards SJ, Misbach SA, Chalmers DM, Axon AT. Granulocyte apheresis in inflammatory bowel disease: possible mechanisms of effect. Ther Apheresis 1998; 2:93-96.